All In MedTech

Device Trial Radar · NCT05285436

A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis

A Prospective Clinical Study to Assess the Clinical Utility of Turbidity With the CloudCath System in Patients Using In-Home Peritoneal Dialysis

Last checked: Nov 20, 2026Latest source record: Sep 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

314

Planned (sponsor's estimate)

Start

Mar 16, 2022

Primary completion

Dec 2024

Study completion Dec 2024

Sponsor

Lead sponsor
CloudCathNot on our public-company list
Sponsor type
Industry
First posted
Mar 17, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to determine if the CloudCath device can detect infections related to peritoneal dialysis (peritonitis) as fast or faster than the current standard methods used by patients and doctors to detect such infections.

Conditions

  • End Stage Renal Disease
  • Peritoneal Dialysis-associated Peritonitis
  • Peritonitis

Interventions

  • CloudCath SystemDevice

    The CloudCath System enables drainage and measures turbidity, reported as a numeric score, in peritoneal dialysate effluent.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to peritonitis diagnosisTime frame: 12-months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dialysis Center of Western Massachusetts Llc

    Chicopee, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.